The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity

Yangchun Xie(Central South University), Shan Zhu(Third Affiliated Hospital of Guangzhou Medical University), Xinxin Song(University of Pittsburgh), Xiaofang Sun(Third Affiliated Hospital of Guangzhou Medical University), Yong Fan(Third Affiliated Hospital of Guangzhou Medical University), Jinbao Liu(Third Affiliated Hospital of Guangzhou Medical University), Meizuo Zhong(Central South University), Hua Yuan(Jilin University), Lin Zhang(University of Pittsburgh), Timothy R. Billiar(University of Pittsburgh), Michael T. Lotze(University of Pittsburgh), Herbert J. Zeh(University of Pittsburgh), Rui Kang(University of Pittsburgh), Guido Kroemer(Délégation Paris 5), Daolin Tang(University of Pittsburgh)
Cell Reports
August 1, 2017
Cited by 933Open Access
Full Text

Abstract

Ferroptosis is a form of regulated cell death that may facilitate the selective elimination of tumor cells. The tumor suppressor p53 (TP53) has been demonstrated to promote ferroptosis via a transcription-dependent mechanism. Here, we show that TP53 limits erastin-induced ferroptosis by blocking dipeptidyl-peptidase-4 (DPP4) activity in a transcription-independent manner. Loss of TP53 prevents nuclear accumulation of DPP4 and thus facilitates plasma-membrane-associated DPP4-dependent lipid peroxidation, which finally results in ferroptosis. These findings reveal a direct molecular link between TP53 and DPP4 in the control of lipid metabolism and may provide a precision medicine strategy for the treatment of colorectal cancer by induction of ferroptosis.


Related Papers

No related papers found

Powered by citation graph analysis